Corvus Pharmaceuticals Inc banner

DCF Value

The DCF Value for Corvus Pharmaceuticals Inc (CRVS) under the Base Case is 3.49 USD. Compared with the current market price of 10.65 USD, the stock appears Overvalued by 67% .

Key assumptions
CRVS DCF Value
Base Case
$3.49
Overvaluation 67%
DCF Value
Price $10.65
Explore More DCF Valuations

Reverse DCF

Single-Assumption Reverse DCF
Stress-test one driver at a time